Evidence map›Paper›PMID 26132074›Full record

ArticlePloS one2015

PET/CT Based In Vivo Evaluation of 64Cu Labelled Nanodiscs in Tumor Bearing Mice.

Pie Huda, Tina Binderup, Martin Cramer Pedersen, Søren Roi Midtgaard, Dennis Ringkjøbing Elema, Andreas Kjær, Mikael Jensen, Lise Arleth

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Nanodiscs: A toolkit for membrane protein science.Protein science : a publication of the Protein Society · 2021
    Review
  8. Antibody Targeted PET Imaging ofBioconjugate chemistry · 2020
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Pie HudaStructural Biophysics, Niels Bohr Institute, University of Copenhagen, Universitetsparken 5, DK-2100 København Ø, Denmark.
Tina BinderupCluster for Molecular Imaging and Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet and University of Copenhagen, Blegdamsvej 3, DK-2200 København N, Denmark.
Martin Cramer PedersenStructural Biophysics, Niels Bohr Institute, University of Copenhagen, Universitetsparken 5, DK-2100 København Ø, Denmark.
Søren Roi MidtgaardStructural Biophysics, Niels Bohr Institute, University of Copenhagen, Universitetsparken 5, DK-2100 København Ø, Denmark.
Dennis Ringkjøbing ElemaHevesy Laboratory, Center for Nuclear Technology, Technical University of Denmark, Frederiksborgvej 399, DK-4000 Roskilde, Denmark.
Andreas KjærCluster for Molecular Imaging and Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet and University of Copenhagen, Blegdamsvej 3, DK-2200 København N, Denmark.
Mikael JensenHevesy Laboratory, Center for Nuclear Technology, Technical University of Denmark, Frederiksborgvej 399, DK-4000 Roskilde, Denmark.
Lise ArlethStructural Biophysics, Niels Bohr Institute, University of Copenhagen, Universitetsparken 5, DK-2100 København Ø, Denmark.
University of Copenhagen · DKTechnical University of Denmark · DKRigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

64Cu radiolabelled nanodiscs based on the 11 α-helix MSP1E3D1 protein and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine lipids were, for the first time, followed in vivo by positron emission tomography for evaluating the biodistribution of nanodiscs. A cancer tumor bearing mouse model was used for the investigations, and it was found that the approximately 13 nm nanodiscs, due to their size, permeate deeply into cancer tissue. This makes them promising candidates for both drug delivery purposes and as advanced imaging agents. For the radiolabelling, a simple approach for 64Cu radiolabelling of proteins via a chelating agent, DOTA, was developed. The reaction was performed at sufficiently mild conditions to be compatible with labelling of the protein part of a lipid-protein particle while fully conserving the particle structure including the amphipathic protein fold.

Indexed as

Copper RadioisotopesNanostructuresPositron-Emission TomographyRadiopharmaceuticalsTomography, X-Ray ComputedAnimalsCell Line, TumorDisease Models, AnimalHeterocyclic Compounds, 1-RingHeterograftsHumansMiceNeoplasmsParticle SizePhosphatidylcholinesTissue Distribution1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid1-palmitoyl-2-oleoylphosphatidylcholineCopper RadioisotopesHeterocyclic Compounds, 1-RingPhosphatidylcholinesRadiopharmaceuticals

Identifiers

PMID26132074
PMCPMC4488450
OpenAlexW2310874336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.